All data are based on the daily closing price as of July 4, 2025
b

Boryung

003850.KO
6.16 USD
-0.09
-1.44%

Overview

Last close
6.16 usd
Market cap
517.37M usd
52 week high
10.04 usd
52 week low
5.24 usd
Target price
11.01 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.6969
Price/Book Value
0.9201
Enterprise Value
607.68M usd
EV/Revenue
0.8166
EV/EBITDA
8.8848

Key financials

Revenue TTM
751.71M usd
Gross Profit TTM
265.13M usd
EBITDA TTM
79.01M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
763.12M usd
Net debt
N/A usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top